PROTAGONIST THERAPEUTICS INC filings

All
Holdings
Significant ownership
Insider transactions
Annual reports
Quarterly reports
Events
Shareholder votes
SEC filings by PROTAGONIST THERAPEUTICS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2021-02-02JOHNSON & JOHNSONProtagonist Therapeutics, Inc2,449,1835.7%EDGAR
SC 13G2021-02-02BlackRock Inc.Protagonist Therapeutics, Inc2,591,7116.2%EDGAR
SC 13G/A2020-06-09BlackRock Inc.Protagonist Therapeutics, Inc1,656,2414.8%EDGAR
SC 13D/A2020-06-08Lilly Ventures Fund I LLCProtagonist Therapeutics, Inc1,559,0604.5%EDGAR
SC 13G2020-05-22ADAGE CAPITAL PARTNERS GP, L.L.C.Protagonist Therapeutics, Inc2,200,0006.4%EDGAR
SC 13G/A2020-02-14BIOTECHNOLOGY VALUE FUND L PProtagonist Therapeutics, Inc1,117,1934.0%EDGAR
SC 13G/A2020-02-14Venrock Healthcare Capital Partners II, L.P.Protagonist Therapeutics, Inc113,1400.4%EDGAR
SC 13G/A2020-02-14PERCEPTIVE ADVISORS LLCProtagonist Therapeutics, Inc00.0%EDGAR
SC 13G/A2020-02-14FARALLON CAPITAL MANAGEMENT LLCProtagonist Therapeutics, Inc527,8231.9%EDGAR
SC 13G/A2020-02-14RTW INVESTMENTS, LPProtagonist Therapeutics, Inc2,459,9889.0%EDGAR
SC 13G/A2020-02-07FMR LLCProtagonist Therapeutics, Inc4,080,96715.0%EDGAR
SC 13G2020-02-07BlackRock Inc.Protagonist Therapeutics, Inc1,561,9575.7%EDGAR
SC 13G2019-12-16RTW INVESTMENTS, LPProtagonist Therapeutics, Inc2,186,6578.0%EDGAR
SC 13G2019-07-01INTEGRATED CORE STRATEGIES (US) LLCProtagonist Therapeutics, Inc811,0663.5%EDGAR
SC 13G2019-06-17Venrock Healthcare Capital Partners II, L.P.Protagonist Therapeutics, Inc1,499,1296.4%EDGAR
SC 13G/A2019-02-14BIOTECHNOLOGY VALUE FUND L PProtagonist Therapeutics, Inc1,247,6295.1%EDGAR
SC 13G/A2019-02-14GREAT POINT PARTNERS LLCProtagonist Therapeutics, Inc955,6184.0%EDGAR
SC 13G/A2019-02-14PERCEPTIVE ADVISORS LLCProtagonist Therapeutics, Inc1,365,5795.6%EDGAR
SC 13G/A2019-02-14FARALLON CAPITAL MANAGEMENT LLCProtagonist Therapeutics, Inc470,7001.9%EDGAR
SC 13G/A2019-02-13FMR LLCProtagonist Therapeutics, Inc3,627,90215.0%EDGAR
External links